Surgical Innovations Group Plc (LON:SUN)‘s stock had its “buy” rating reaffirmed by N+1 Singer in a report issued on Monday, August 7th. They currently have a GBX 5.50 ($0.07) price objective on the stock. N+1 Singer’s price target would indicate a potential upside of 27.91% from the company’s current price.

Shares of Surgical Innovations Group Plc (LON:SUN) opened at 4.30 on Monday. Surgical Innovations Group Plc has a 52-week low of GBX 1.87 and a 52-week high of GBX 5.15. The firm has a 50-day moving average of GBX 3.89 and a 200 day moving average of GBX 3.68. The company’s market capitalization is GBX 22.94 million.

COPYRIGHT VIOLATION NOTICE: This article was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at

In other news, insider Paul Hardy acquired 815,721 shares of the business’s stock in a transaction that occurred on Thursday, July 27th. The stock was acquired at an average price of GBX 3 ($0.04) per share, with a total value of £24,471.63 ($31,768.96).

Surgical Innovations Group Plc Company Profile

Surgical Innovations Group plc is a United Kingdom-based holding company, which is involved in the design, development, manufacture and sale of devices for use in minimally invasive surgery (SI) and precision engineering (PE) markets. The Company sells branded products through independent healthcare distributors across the world and own label products through original equipment manufacturer (OEM) relationships.

Receive News & Stock Ratings for Surgical Innovations Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgical Innovations Group Plc and related stocks with our FREE daily email newsletter.